Progression from F3 to cirrhosis occurred in roughly one year, contrasting STELLAR’s 13% over four years and suggesting trials may underrepresent real-world risk. Among compensated cirrhosis, 29.7% ...
Zacks Investment Research on MSN
Delta Air Lines (DAL) expected to beat earnings estimates: Should you buy?
Delta Air Lines (DAL) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results ...
Microsoft commits $2.5 billion to AI innovation, fueling advancements in technology and redefining industry standards for the future.
There is a specific kind of person who checks quarterly SEC filings the way other people check sports scores. Devon Okafor is one of them. He runs a ...
Objective Sarcopenia, defined by reductions in muscle mass and strength, increases the risk of adverse outcomes in patients with rheumatoid arthritis (RA)—driven in part by chronic inflammation—and is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results